Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Journal of Medicinal Chemistry|September 6, 2002
Monoclonal antibody conjugates of doxorubicin prepared with branched peptide linkers: inhibition of aggregation by methoxytriethyleneglycol chainsH Dalton King, Gene M Dubowchik, Harold Mastalerz, et al.Bioorganic & Medicinal Chemistry Letters|May 29, 2002
Doxorubicin immunoconjugates containing bivalent, lysosomally-cleavable dipeptide linkagesGene M Dubowchik, Shilpa Radia, Harold Mastalerz, et al.Acta Crystallographica. Section F, Structural Biology Communications|March 19, 2014
The structure of human tau-tubulin kinase 1 both in the apo form and in complex with an inhibitorSusan E Kiefer, Chiehying J Chang, S Roy Kimura, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
Preclinical antitumor activity of BMS-599626, a pan-HER kinase inhibitor that inhibits HER1/HER2 homodimer and heterodimer signalingTai W Wong, Francis Y Lee, Chiang Yu, et al.Bioorganic & Medicinal Chemistry Letters|December 24, 2010
Novel pyrrolo[2,1-f][1,2,4]triazin-4-amines: Dual inhibitors of EGFR and HER2 protein tyrosine kinasesBrian E Fink, Derek Norris, Harold Mastalerz, et al.Bioorganic & Medicinal Chemistry Letters|August 23, 2005
New dual inhibitors of EGFR and HER2 protein tyrosine kinasesBrian E Fink, Gregory D Vite, Harold Mastalerz, et al.Bioorganic & Medicinal Chemistry|September 18, 2003
The discovery of BMS-275183: an orally efficacious novel taxaneHarold Mastalerz, Donald Cook, Craig R Fairchild, et al.Bioorganic & Medicinal Chemistry Letters|March 21, 2007
Novel C-5 aminomethyl pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinasesHarold Mastalerz, Ming Chang, Ashvinikumar Gavai, et al.Bioorganic & Medicinal Chemistry Letters|July 4, 2007
5-((4-Aminopiperidin-1-yl)methyl)pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinasesHarold Mastalerz, Ming Chang, Ping Chen, et al.Bioorganic & Medicinal Chemistry Letters|February 3, 2007
New C-5 substituted pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinasesHarold Mastalerz, Ming Chang, Ping Chen, et al.Pageof 2